Presented at the 79th ASRM Scientific Congress & Expo, Shady Grove Fertility’s research team provides reassuring data that patients undergoing egg retrieval can keep IUDs in place without concerns for negative outcomes for the eggs retrieved in a cycle.
ROCKVILLE, Md. [October 17, 2023] – New research from Shady Grove Fertility (SGF), a US Fertility practice, will allow patients with IUDs to proceed with ovarian stimulation and egg retrieval, knowing that their contraceptive of choice can remain in place providing confidence that IUDs do not reduce the number of eggs retrieved.
“Women who are considering fertility preservation are often worried about keeping their IUDs in place throughout the egg retrieval cycle,” shares Phillip A. Romanski, M.D., M.Sc., SGF Director of Research and fertility specialist at SGF New York. “Our research team was excited to learn that patients can rest assured they can keep their IUDs in place without worrying about the impact of eggs retrieved. This important research can help many women take that next step toward preserving their fertility to help build their future family.”
The retrospective cohort study, Comparison of Oocyte Cryopreservation Retrieval Outcomes Among Patients with Progestin Secreting, Copper, or No Intrauterine Device, was conducted by SGF physicians Kate Devine, M.D.; Benjamin S. Harris, M.D., M.P.H.; and Phillip A. Romanski, M.D., M.Sc.; and US Fertility’s Samad Jahandideh, Ph.D.; alongside Brooklyn, NY medical resident Haggar Zoe Aspitz, M.D., B.S.; University of Southern California REI fellow Adriana J. Wong, M.D., M.P.H, ; and National Institute of Child Health and Human Development, REI fellow Charlene G. Echague, D.O..
The study fills a gap in research surrounding egg retrieval outcomes and both progestin-containing and copper IUDs. The research teams evaluated donor egg cycles at SGF from 2010-2021. In total, 5,428 egg donors were included – 133 with progestin IUDs, 146 with copper IUDs, and 2,891 without a contraceptive intrauterine device in place. Donors in their egg donation cycle with an IUD in place had comparable results to those without an IUD.
Learn more about Shady Grove Fertility’s Research Team, which conducts and publishes high-quality research studies to advance the field of reproductive medicine to provide the most up to date, and evidence-based care for patients.
About Shady Grove Fertility (SGF)
SGF is a leading fertility and IVF center of excellence with more than 100,000 babies born from 30+ years of continuous innovation and patient-centered fertility care. With convenient locations throughout the U.S. and in Santiago, Chile, SGF accepts most insurance plans and makes fertility treatment accessible and affordable through innovative financial solutions, including 100% refund guarantees for eligible patients. SGF is a proud partner practice of US Fertility, the largest physician-owned and physician-led partnership of top-tier fertility practices nationally. Call 1-888-761-1967 to schedule a new patient appointment or visit ShadyGroveFertility.com for more information.
About US Fertility
US Fertility, the nation’s largest partnership of physician-owned and physician-led top-tier fertility practices, along with Ovation Fertility, a national network of premier IVF laboratories, are united under a shared mission to deliver the joy of parenthood through advanced reproductive medicine and innovative science. To date, US Fertility and Ovation Fertility practices have helped more than 225,000 individuals and couples build their families using assisted reproductive technology. US Fertility supports over 200 physicians by leveraging collective expertise, driving innovation, and by providing advanced business and digital solutions that streamline and enhance the delivery of exceptional patient care. Together with a growing suite of life science services, US Fertility is expanding access to the highest quality reproductive health care across over 100 clinic locations and 32 IVF laboratories. Visit www.USFertility.com for more information.
